Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Melander

Showing results (201-210 of 272) with videos related to

Pageof 28
Sort By:
Acta Medica Scandinavica. Supplementum|January 1, 1981
Oral antidiabetic therapyA Melander, L O Almér, G Sartor, et al.
European Journal of Clinical Pharmacology|April 17, 1999
Utilization of cardiovascular drugs (blood pressure lowering drugs, lipid lowering drugs and nitrates) and mortality from ischaemic heart disease and stroke. An ecological analysis based on Sweden's municipalitiesJ Merlo, G Lindberg, U Lindblad, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Lack of primary effect of sulphonylurea (glipizide) on plasma lipoproteins and insulin action in former type 2 diabetics with attenuated insulin secretionG Sartor, D Ursing, P Nilsson-Ehle, et al.
Acta Endocrinologica|February 1, 1987
3,4-Dihydroxypyridine: a potential antithyroid drugB Hallengren, M P Hegarty, A Forsgren, et al.
Clinical Pharmacokinetics|May 1, 1986
Reduction of paracetamol and aspirin metabolism during viral hepatitisC Jorup-Rönström, B Beermann, E Wåhlin-Boll, et al.
Diabetes Care|August 1, 1990
Will sulfonylurea treatment of impaired glucose tolerance delay development and complications of NIDDM?A Melander, P O Bitzén, G Sartor, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Long-term effects of glipizide on insulin secretion and blood glucose control in patients with non-insulin-dependent diabetes mellitusP O Bitzén, A Melander, B Scherstén, et al.
Dementia and Geriatric Cognitive Disorders Extra|November 3, 2018
The Impact of Using Measurements of Electrodermal Activity in the Assessment of Problematic Behaviour in DementiaCatharina A Melander, Basel Kikhia, Malin Olsson, et al.
Acta Endocrinologica|February 1, 1977
Secretion of thyroxine, 3,5,3'-triiodothyronine and 3,3'5'-triiodothyronine in euthyroid manU Westgren, A Melander, S Ingemansson, et al.
Acta Medica Scandinavica|January 1, 1976
Blood levels of 3,5,3'-triiodothyronine and thyroxine: differences between children, adults, and elderly subjectsU Westgren, A Burger, S Ingemansson, et al.
Pageof 28

Showing results (201-210 of 272) with videos related to

Sort By:
Pageof 28
Acta Medica Scandinavica. Supplementum|January 1, 1981
Oral antidiabetic therapyA Melander, L O Almér, G Sartor, et al.
European Journal of Clinical Pharmacology|April 17, 1999
Utilization of cardiovascular drugs (blood pressure lowering drugs, lipid lowering drugs and nitrates) and mortality from ischaemic heart disease and stroke. An ecological analysis based on Sweden's municipalitiesJ Merlo, G Lindberg, U Lindblad, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Lack of primary effect of sulphonylurea (glipizide) on plasma lipoproteins and insulin action in former type 2 diabetics with attenuated insulin secretionG Sartor, D Ursing, P Nilsson-Ehle, et al.
Acta Endocrinologica|February 1, 1987
3,4-Dihydroxypyridine: a potential antithyroid drugB Hallengren, M P Hegarty, A Forsgren, et al.
Clinical Pharmacokinetics|May 1, 1986
Reduction of paracetamol and aspirin metabolism during viral hepatitisC Jorup-Rönström, B Beermann, E Wåhlin-Boll, et al.
Diabetes Care|August 1, 1990
Will sulfonylurea treatment of impaired glucose tolerance delay development and complications of NIDDM?A Melander, P O Bitzén, G Sartor, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Long-term effects of glipizide on insulin secretion and blood glucose control in patients with non-insulin-dependent diabetes mellitusP O Bitzén, A Melander, B Scherstén, et al.
Dementia and Geriatric Cognitive Disorders Extra|November 3, 2018
The Impact of Using Measurements of Electrodermal Activity in the Assessment of Problematic Behaviour in DementiaCatharina A Melander, Basel Kikhia, Malin Olsson, et al.
Acta Endocrinologica|February 1, 1977
Secretion of thyroxine, 3,5,3'-triiodothyronine and 3,3'5'-triiodothyronine in euthyroid manU Westgren, A Melander, S Ingemansson, et al.
Acta Medica Scandinavica|January 1, 1976
Blood levels of 3,5,3'-triiodothyronine and thyroxine: differences between children, adults, and elderly subjectsU Westgren, A Burger, S Ingemansson, et al.
Pageof 28